Fresenius
Price
Price
Historical dividends and forecast
The next dividend will be paid on 23.05.2025
CHART BY
Frequently asked questions
What is Fresenius's market capitalization?
What is the Earnings Per Share (EPS) for Fresenius?
What are the analyst ratings and target price for Fresenius's stock?
What is Fresenius's revenue over the trailing twelve months?
What is the EBITDA for Fresenius?
What is the free cash flow of Fresenius?
What is the 5-year beta of Fresenius's stock?
How many employees does Fresenius have, and what sector and industry does it belong to?
What is the free float of Fresenius's shares?
Financials
Market Cap
$19.00B5Y beta
1.05EPS (TTM)
-$0.71Free Float
411.39MRevenue (TTM)
$22.92BEBITDA (TTM)
$4.23BFree Cashflow (TTM)
$2.23BPricing
Analyst Ratings
The price target is $37.80 and the stock is covered by 20 analysts.
Buy
14
Hold
6
Sell
0
Information
Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes in intravenously administered generic drugs (IV drugs), clinical nutrition and infusion therapies. It also supplies hospitals with medical devices and products of transfusion technology. Fresenius Helios is a private hospital operator, with over 130 facilities in Germany, including maximum care hospitals and rehabilitation centers and, through Quironsalud, over 80 hospitals and outpatient centers, as well as approximately 300 Occupational Risk Prevention Centers in Spain. Fresenius Vamed manages projects and provides services for health care facilities worldwide, from development and turnkey construction to maintenance and total operational management.
177,091
Healthcare Facilities
Health Care
Identifier
ISIN
Primary Ticker